Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicle size and distribution vary significantly across different body sites.

Injecting platelet-rich plasma during hair transplant surgery improves hair regrowth rate, speeds up skin recovery, and enhances hair quality.

Madarosis is the loss of eyelashes and eyebrows due to various health issues and requires thorough examination to diagnose and treat the underlying cause.

P-cadherin is crucial for hair follicle pigmentation but not skin pigmentation.

Using neurohormones to control keratin can lead to new skin disease treatments.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

Low-dose oral minoxidil effectively reduces hair loss in women with female pattern hair loss.

Transfollicular drug delivery is promising but needs more research to improve and understand it better.

Hair loss from conditions like LPP and FFA can potentially be reversed with the right treatment.

Western diet may cause male pattern baldness; low glycemic diet with magnesium could help.

Nanostructured delivery systems could potentially improve hair loss treatment by targeting drugs to hair follicles, reducing side effects and dosage, but the best size, charge, and materials for these systems need further investigation.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Light therapy might help treat hereditary hair loss by improving hair follicle growth in lab cultures.

Thyroid problems can cause hair loss and change hair texture.

The document concludes that using stem cells to regenerate hair follicles could be a promising treatment for hair loss, but there are still challenges to overcome before it can be used clinically.

Benign skin adnexal tumors are more common than malignant ones, with trichoepithelioma and chondroid syringoma being the most frequent types.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Natural products and phytochemicals may help with hair regrowth, but more research is needed.

DHT, a testosterone byproduct, causes male pattern baldness.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

AGA can occur in children with family history; early diagnosis and treatment important.

The document concludes that better treatments for CCCA are needed and more research is required to understand its causes related to hairstyling and genetics.

A rare hair follicle disorder can cause itchy, bluish-black bumps on the body.

Yellow dots and short vellus hairs are the most common signs of Alopecia Areata (AA), and trichoscopy can help diagnose AA and track treatment progress.

Using dermoscopy improves diagnosis of scalp and hair disorders in children.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

ALRV5XR effectively increases hair density in men with androgenetic alopecia without adverse effects.

Transverse scalp biopsy sections help diagnose different alopecias by showing hair follicle details and inflammation patterns.

Treating hair loss effectively may require a multi-sided approach, using different treatments together, and topical treatments could be more effective and safer than oral ones.